In this article
- Large Israeli Study Reveals Adolescent Obesity Significantly Increases Pancreatic Cancer Risk in Adulthood
- Understanding Obesity Beyond Cancer Risk and Global Childhood Obesity Statistics
- Twenty Three Year Follow Up Study of Nearly Two Million Young Adults Tracks Pancreatic Cancer Development
- Gender Differences in Pancreatic Cancer Risk Show Men Vulnerable Even at Overweight BMI Levels
- Inflammation Mechanism and Population Impact of Adolescent Obesity on Pancreatic Cancer Development
- How CancerFax Helps
Adolescent obesity is associated with many health problems in later life, and a large Israeli study has shown that the increased risk of fatal pancreatic cancer is one of them. For more than 20 years, researchers have tracked nearly 2 million men and women. Compared with adolescents with normal weight, adolescent obese men have more than three times the risk of pancreatic cancer in adulthood, and adolescent obese women have more than four times the risk of pancreatic cancer.
Current research does not prove that obesity causes pancreatic cancer, but it does increase the risk of potential health problems. Chanan Meydan of Mayanei HaYeshua Medical Center in Bnei Brak, Israel, said, "Even without considering cancer, it is necessary to fight obesity, especially for the prevention and treatment of cardiovascular diseases." According to data from the World Health Organization, on a global scale, Nearly one in five children and adolescents are overweight or obese. Children and adolescents are considered obese when their body mass index (BMI) (weight to height ratio) is higher than 95% of other young people of the same age and gender. BMI is considered overweight in the 85th to 95th percentile range.
In order to study the relationship between obesity and pancreatic cancer, the researchers analyzed the weight data of nearly 1.1 million men and more than 707,000 women who were compulsory for medical examinations between 16 and 19 years of age. When half of the people in the study were tracked for at least 23 years, the researchers looked at national cancer registry data, during which 423 men and 128 women were diagnosed with pancreatic cancer.
The study found that even if the weight of adolescence is not enough to make them considered obese, men's risk of pancreatic cancer will increase. Just because adolescents are overweight leads to a 97% increased risk of pancreatic cancer later in life. And, at the high end of the normal weight range, BMI is in the 75th to 85th percentiles, which is associated with a 49% increase in pancreatic cancer risk. Women only have a greater risk of pancreatic cancer when they are obese, not when they are overweight.
Dr. Zohar Levi, author of this study, wrote in the journal Cancer that overweight in adolescence may explain about 11% of pancreatic cancer cases in the population. The study authors pointed out that inflammation caused by overweight may lead to tumor development. More research is needed to further clarify how anti-obesity interventions reduce the risk of malignant tumors
How CancerFax Helps
CancerFax is a specialist cancer access and patient-navigation platform. We help patients and families understand their options, organise medical records, coordinate hospital communication, and support cross-border treatment planning where appropriate.
We help collect and organise reports, scans, pathology, biomarker results, and treatment history for structured case review.
We communicate with hospitals or trial teams to assess whether a case may be suitable for further screening.
We support appointment coordination, document submission, translation, and direct communication with international departments.
For international patients, we help with practical coordination — travel planning, hospital admission guidance, and local support.
If this option is not suitable, we help explore other relevant treatments, clinical trials, or advanced care pathways.
From inquiry through to follow-up, our coordinators provide a single point of contact for the family.
CancerFax does not guarantee treatment access, eligibility, or clinical outcome. Our role is to help patients access accurate information, structured review, and appropriate specialist pathways.
Medical Disclaimer
This article is for educational purposes only and should not replace medical advice, diagnosis, or treatment from a qualified oncology specialist. Every patient's case is different. Treatment decisions should always be made after a review of complete medical records by the treating medical team.
Treatment availability, eligibility, timelines, and access can change. Any clinical trial participation depends on detailed review and approval by the trial hospital or investigator.